183 related articles for article (PubMed ID: 28692111)
1. A randomised trial on the effect of anti-platelet therapy on the systemic inflammatory response in human endotoxaemia.
Kiers D; van der Heijden WA; van Ede L; Gerretsen J; de Mast Q; van der Ven AJ; El Messaoudi S; Rongen GA; Gomes M; Kox M; Pickkers P; Riksen NP
Thromb Haemost; 2017 Aug; 117(9):1798-1807. PubMed ID: 28692111
[TBL] [Abstract][Full Text] [Related]
2. Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model.
Thomas MR; Outteridge SN; Ajjan RA; Phoenix F; Sangha GK; Faulkner RE; Ecob R; Judge HM; Khan H; West LE; Dockrell DH; Sabroe I; Storey RF
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2562-70. PubMed ID: 26515417
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.
Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085
[TBL] [Abstract][Full Text] [Related]
4. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet function with clopidogrel is associated with a reduction of inflammation in patients with peripheral artery disease.
Meyer A; Weithaeuser A; Steffens D; Bobbert P; Hassanein A; Ayral Y; Schultheiss HP; Rauch U
Cardiovasc Revasc Med; 2016; 17(3):169-75. PubMed ID: 27157293
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of enhanced inhibition of P2Y12-mediated platelet aggregation in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Capranzano P; Mehran R; Tamburino C; Stone GW; Dangas G
Hosp Pract (1995); 2010 Nov; 38(4):38-43. PubMed ID: 21068525
[TBL] [Abstract][Full Text] [Related]
8. Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy.
Verdoia M; Nardin M; Sartori C; Pergolini P; Rolla R; Barbieri L; Marino P; Bellomo G; Suryapranata H; De Luca G;
Atherosclerosis; 2015 Dec; 243(2):389-94. PubMed ID: 26520891
[TBL] [Abstract][Full Text] [Related]
9. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
[TBL] [Abstract][Full Text] [Related]
10. Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease.
Angiolillo DJ; Jakubowski JA; Ferreiro JL; Tello-Montoliu A; Rollini F; Franchi F; Ueno M; Darlington A; Desai B; Moser BA; Sugidachi A; Guzman LA; Bass TA
J Am Coll Cardiol; 2014 Sep; 64(10):1005-14. PubMed ID: 25190236
[TBL] [Abstract][Full Text] [Related]
11. [Antiplatelet agents and transfusion].
Gaussem P; Martin AC; Belleville-Rolland T; Helley D; Bachelot-Loza C; Godier A
Transfus Clin Biol; 2017 Sep; 24(3):160-165. PubMed ID: 28645644
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Antiplatelet Effects of Once and Twice Daily Low-Dose Ticagrelor and Clopidogrel After Percutaneous Coronary Intervention.
Choi KN; Jin HY; Shin HC; Park YA; Seo JS; Jang JS; Yang TH; Kim DK; Kim DS
Am J Cardiol; 2017 Jul; 120(2):201-206. PubMed ID: 28554486
[TBL] [Abstract][Full Text] [Related]
13. A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysis.
Westman PC; Lipinski MJ; Torguson R; Waksman R
Cardiovasc Revasc Med; 2017 Mar; 18(2):79-85. PubMed ID: 28089137
[TBL] [Abstract][Full Text] [Related]
14. Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors.
Adamski P; Koziński M; Ostrowska M; Fabiszak T; Navarese EP; Paciorek P; Grześk G; Kubica J
Thromb Haemost; 2014 Aug; 112(2):224-42. PubMed ID: 24763899
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies.
Jeong YH; Bliden KP; Antonino MJ; Park KS; Tantry US; Gurbel PA
Am Heart J; 2012 Jul; 164(1):35-42. PubMed ID: 22795280
[TBL] [Abstract][Full Text] [Related]
16. Ticagrelor: a novel oral antiplatelet agent.
Huang NS; Master HH; Fusco JA; Park ZH
Consult Pharm; 2010 Nov; 25(11):745-55. PubMed ID: 21138823
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.
Schrottmaier WC; Kral JB; Badrnya S; Assinger A
Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241
[TBL] [Abstract][Full Text] [Related]
18. Emerging oral antiplatelet therapies for acute coronary syndromes.
Pollack CV
Hosp Pract (1995); 2010 Nov; 38(4):29-37. PubMed ID: 21068524
[TBL] [Abstract][Full Text] [Related]
19. Aspirin, clopidogrel, and ticagrelor in acute coronary syndromes.
Berger JS
Am J Cardiol; 2013 Sep; 112(5):737-45. PubMed ID: 23751937
[TBL] [Abstract][Full Text] [Related]
20. Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Aradi D; Komócsi A; Vorobcsuk A; Serebruany VL
Thromb Haemost; 2013 Jan; 109(1):93-101. PubMed ID: 23197191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
